However, Glenn Micalizio, a chemist at Scripps, and his colleagues didn't become interested in the compound as a result of its pharmaceutical potential. Instead, they realized that its elaborate carbon skeleton was an excellent concentrate on for testing a type of response that they experienced lately devised.Don't take JOURNAVX if you take sure me